Buhl T, Georg B, Nilsson C, Mikkelsen J D, Wulff B S, Fahrenkrug J
University Department of Clinical Biochemistry, Bispebjerg Hospital, Copenhagen, Denmark.
Regul Pept. 1995 Feb 14;55(3):237-51. doi: 10.1016/0167-0115(94)00112-b.
We report here data on the expression of the various sequences derived from the prepro-vasoactive intestinal polypeptide (VIP) precursor and VIP mRNA in the anterior pituitary gland and cerebral cortex of hypothyroid and hyperthyroid rats. Using specific antisera to each of the prepro-VIP sequences we demonstrated an increase of all prepro-VIP derived sequences, and accordingly, found that the number of cells expressing each of these sequences were markedly augmented in the anterior pituitary of the hypothyroid rats. This was accompanied by a marked increase in VIP mRNA. In the cerebral cortex of the hypothyroid rats no changes were observed. In the pituitary of hyperthyroid animals a significant decrease was seen for prepro-VIP 22-79, VIP and prepro-VIP 156-170, whereas in the cerebral cortex a significant increase was observed for prepro-VIP 22-79, PHI and VIP. We were not able to demonstrate any changes in VIP mRNA in the cerebral cortex or pituitary of the hyperthyroid rats. Gel permeation chromatography and reverse-phase HPLC of extracts from cerebral cortex showed elution profiles identical to the synthetic counterparts. The reported data provide further evidence of a tissue-specific expression and regulation of the VIP gene products.
我们在此报告关于甲状腺功能减退和甲状腺功能亢进大鼠的垂体前叶和大脑皮质中,源自血管活性肠肽(VIP)前体原的各种序列及VIP mRNA表达的数据。使用针对每个前体原VIP序列的特异性抗血清,我们证明了所有源自前体原VIP的序列均增加,相应地,我们发现表达这些序列的细胞数量在甲状腺功能减退大鼠的垂体前叶中显著增加。这伴随着VIP mRNA的显著增加。在甲状腺功能减退大鼠的大脑皮质中未观察到变化。在甲状腺功能亢进动物的垂体中,前体原VIP 22 - 79、VIP和前体原VIP 156 - 170显著减少,而在大脑皮质中,前体原VIP 22 - 79、PHI和VIP显著增加。我们未能证明甲状腺功能亢进大鼠的大脑皮质或垂体中VIP mRNA有任何变化。大脑皮质提取物的凝胶渗透色谱和反相高效液相色谱显示洗脱图谱与合成对应物相同。所报告的数据为VIP基因产物的组织特异性表达和调节提供了进一步的证据。